Oxford Nanopore (ONT.L) traded down -0.47 % during a 24 hours period ending at 03:12 PM Central Europe on Monday 26th. One Oxford Nanopore stock can currently be bought for about GBX 210 on popular exchanges. Current supply of Oxford Nanopore stocks is 978.4 mn. Oxford Nanopore has a current market capitalization of GBX 2.8 bn and approximately GBX 194 mn worth of Oxford Nanopore was traded on exchanges in the last 24 hours. Since last month end, Oxford Nanopore has traded 21.27 % up. Simple moving average of last 200 days is at GBX 139.93. The highest price of past 52 weeks was recorded at GBX 238.8 on 10/06/2026. 52 weeks low was at GBX 95.61 on 07/13/2026.

Here is how related stocks have performed in the past 24 hours:

  • Hamilton Global Opportunitie (ALHGO.PA) traded flat 0 % and now trades at EUR 41.8. Current market capitalisation for Hamilton Global Opportunitie is EUR 26.3 mn. Hamilton Global Opportunitie has a current price to earnings ratio of 3.58.

  • Allianz (ATT.L) traded flat 0 % and now trades at GBX 691. Allianz has a market capitalisation of GBX 2.9 bn. Current price/earnings ratio for Allianz is 2.

  • Inchcape (INCH.L) traded up 2.08 % and now trades at GBX 651. Inchcape has a market capitalisation of GBX 3 bn. Current price/earnings ratio for Inchcape is 9.99.

  • Hill & Smith (HILS.L) traded down -1.38 % and now trades at GBX 2,895. Hill & Smith has a market capitalisation of GBX 3 bn. Current price/earnings ratio for Hill & Smith is 24.

  • Quilter (QLT.L) traded up 0.83 % and now trades at GBX 184.9. Quilter has a market capitalisation of GBX 3.3 bn. Current price/earnings ratio for Quilter is 21.28. Quilter PLC reported that it has carried out a series of share‑buy‑back transactions on the London Stock Exchange. Over the past week the company purchased ordinary shares from a broker, with the purchases averaging a modest premium relative to the market level. The repurchase programme is ongoing, and the company intends to cancel the acquired shares, thereby reducing the number of shares held in treasury. Since early September, the total volume of shares bought has been substantial, and the company remains a publicly listed entity with no treasury shares remaining. The company has provided a detailed disclosure of the transactions in an official filing, confirming the execution of the buy‑back and its alignment with the company’s capital management strategy.

About Oxford Nanopore

Oxford Nanopore Technologies PLC is a health care sector company based in Oxford, United Kingdom. The company specializes in developing technologies for molecular detection and analysis. These technologies find applications in deoxyribonucleic acid (DNA) sequencing, diagnostics, drug development, biomolecular interaction, ion channel screening, and defense applications. By providing innovative solutions to customers worldwide, Oxford Nanopore Technologies PLC is at the forefront of molecular detection and analysis.